[Asia Economy Reporter Oh Ju-yeon] Bifido announced on the 13th that it has acquired a patent for a composition containing Bifidobacterium for the improvement, treatment, or prevention of rheumatoid arthritis. The company explained, "Our Bifidobacterium bifidum ATT strain reduces the expression of IL-8, a cytokine overexpressed by arthritis stimulants, back to pre-overexpression levels, demonstrating efficacy in the prevention or treatment of rheumatoid arthritis."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing